FDA Inspection
Contacare Ophthalmics & DiagnosticsContacare Ophthalmics & Diagnostics – FDA Inspection, Nov 1, 2018
Record Details
This FDA Inspection record concerns Contacare Ophthalmics & Diagnostics, with an inspection on November 1, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 75b7c488-50ea-446f-8cf5-43f873045847
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1070443
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
11- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.42(c)(10)Aseptic Processing Area
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Contacare Ophthalmics & Diagnostics
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 4, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 29, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Contacare Ophthalmics & Diagnostics
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.